메뉴 건너뛰기




Volumn 33, Issue 2, 2006, Pages 433-

Should anti-tumor necrosis factor-α be the first therapy for rheumatoid vasculitis? [1]

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 32144438288     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (9)

References (7)
  • 1
    • 5044226801 scopus 로고    scopus 로고
    • Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis
    • Richette P, Dieude P, Diamiano J, et al. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 2004;31:2079-81.
    • (2004) J Rheumatol , vol.31 , pp. 2079-2081
    • Richette, P.1    Dieude, P.2    Diamiano, J.3
  • 2
    • 5044220918 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha blockade and the risk of vasculitis
    • Guillevin L, Mouthon L. Tumor necrosis factor alpha blockade and the risk of vasculitis. J Rheumatol 2004;31:1885-7.
    • (2004) J Rheumatol , vol.31 , pp. 1885-1887
    • Guillevin, L.1    Mouthon, L.2
  • 3
    • 17144376033 scopus 로고    scopus 로고
    • Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab
    • Armstrong DJ, McCarron MT, Wright GD. Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab [letter]. J Rheumatol 2005;32:759.
    • (2005) J Rheumatol , vol.32 , pp. 759
    • Armstrong, D.J.1    McCarron, M.T.2    Wright, G.D.3
  • 4
    • 0036107868 scopus 로고    scopus 로고
    • Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor monoclonal antibody infliximab
    • Garcia-Porrua C, Gonzalez-Gay MA. Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor monoclonal antibody infliximab. Rheumatology Oxford 2002;41:234-5.
    • (2002) Rheumatology Oxford , vol.41 , pp. 234-235
    • Garcia-Porrua, C.1    Gonzalez-Gay, M.A.2
  • 5
    • 0344172156 scopus 로고    scopus 로고
    • Systemic vasculitis in adults in Northwestern Spain, 1988-1997: Clinical and epidemiologic aspects
    • Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in Northwestern Spain, 1988-1997: Clinical and epidemiologic aspects. Medicine Baltimore 1999;78:292-308.
    • (1999) Medicine Baltimore , vol.78 , pp. 292-308
    • Gonzalez-Gay, M.A.1    Garcia-Porrua, C.2
  • 6
    • 0031787155 scopus 로고    scopus 로고
    • Fatal interstitial pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus
    • Garcia-Porrua C, Gonzalez-Gay MA, Perez de Llano LA, Alvarez-Ferreira J. Fatal interstitial pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus. Scand J Rheumatol 1998;27:465-6.
    • (1998) Scand J Rheumatol , vol.27 , pp. 465-466
    • Garcia-Porrua, C.1    Gonzalez-Gay, M.A.2    Perez De Llano, L.A.3    Alvarez-Ferreira, J.4
  • 7
    • 0031660364 scopus 로고    scopus 로고
    • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
    • Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
    • (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
    • Maini, R.N.1    Breedveld, F.C.2    Kalden, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.